Elan has received approval from the US Food and Drug Administration for ziconotide which is used in the treatment of chronic pain. Announcing the approval, Elan chairman and chief executive Mr Donal Geaney said the company is looking forward to working with the FDA.
Elan gets US drugs approval
Elan has received approval from the US Food and Drug Administration for ziconotide which is used in the treatment of chronic …
Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective








